Jones Trading sets OnKure stock Buy rating, $32 target
Jones Trading initiated coverage on OnKure Therapeutics Inc. (NASDAQ:OKUR) with a Buy rating and a price target of $32.00.
OnKure Therapeutics initiated with a Buy at JonesResearch
JonesResearch initiated coverage of OnKure Therapeutics (OKUR) with a Buy rating and $32 price target. The clinical stage precision oncology ...
Positive Outlook for Relay Therapeutics: Buy Rating on Promising RLY-2680 Developments and Market Opportunities
JMP Securities analyst Silvan Tuerkcan maintained a Buy rating on Relay Therapeutics (RLAY – Research Report) today and set a price target of ...
pharmaphorum18h
Pharma holds it breath for ’25 as the sun shines on JP Morgan conference
The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...